Xiaoping Cai
Impact in
-
- Advanced biosensing and bioanalysis techniques
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Circular RNAs in diseases
- Protein Interaction Studies and Fluorescence Analysis
Papers in
-
- Circular RNAs in diseases 4
- Amyloidosis: Diagnosis, Treatment, Outcomes 3
- DNA Repair Mechanisms 2
- Histone Deacetylase Inhibitors Research 2
- Co-authors
- Zhuo Cao (9 shared papers)Paul K. Witting (4 shared papers)Junping Zhang (4 shared papers)Ben Freedman (3 shared papers)Hao Zheng (7 shared papers)Yanchun Wang (2 shared papers)Aihua Zhang (2 shared papers)Yuling Li (7 shared papers)
In The Last Decade
Xiaoping Cai
31 papers receiving 319 citations
Peers
Comparison fields: 5 of 78
- Molecular Medicine 15
- Molecular Biology 186
- Complementary and alternative medicine 21
- Cancer Research 31
- Applied Microbiology and Biotechnology 4
Countries citing papers authored by Xiaoping Cai
This map shows the geographic impact of Xiaoping Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Cai more than expected).
Fields of papers citing papers by Xiaoping Cai
This network shows the impact of papers produced by Xiaoping Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Cai. The network helps show where Xiaoping Cai may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 31 | |
| 2 | 2012 | 29 | |
| 3 | 2015 | 28 | |
| 4 | 2022 | 23 | |
| 5 | 2020 | 22 | |
| 6 | 2021 | 19 | |
| 7 | 2016 | 18 | |
| 8 | 2014 | 17 | |
| 9 | 2019 | 17 | |
| 10 | 2019 | 16 | |
| 11 | 2013 | 15 | |
| 12 | 2021 | 13 | |
| 13 | 2021 | 10 | |
| 14 | 2017 | 10 | |
| 15 | 2024 | 7 | |
| 16 | [beta-elemene enhances aclarubicin-induced apoptotic effect in HL-60 cells and its mechanism.]. | 2009 | 6 |
| 17 | 2016 | 6 | |
| 18 | 2016 | 5 | |
| 19 | 2021 | 4 | |
| 20 | 2024 | 4 |
About Xiaoping Cai
Xiaoping Cai is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Genetics, having authored 32 papers that have together received 323 indexed citations. Recurring topics across this work include Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (4 papers), Electrochemical sensors and biosensors (3 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), Acute Myeloid Leukemia Research (3 papers), DNA Repair Mechanisms (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Molecular Medicine (15 citations), Molecular Biology (186 citations), Complementary and alternative medicine (21 citations), Cancer Research (31 citations) and Applied Microbiology and Biotechnology (4 citations). Xiaoping Cai has collaborated with scholars based in China and Australia. Frequent co-authors include Zhuo Cao, Paul K. Witting, Junping Zhang, Ben Freedman, Hao Zheng, Yanchun Wang, Aihua Zhang, Yuling Li, Xiaosuo Wang and Liangxing Wang. Their work appears in journals such as Discovery Medicine, International Journal of Molecular Sciences, Molecules, Cancer Biotherapy and Radiopharmaceuticals and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.